NCT06769087

Brief Summary

The enhanced recovery after surgery (ERAS) program is widely applied in colorectal cancer surgery. Among the early recovery programs after surgery, the timing of removal of the urinary catheter after surgery has been emphasized recently, but the specific timing is still under discussion. Maintaining the urinary catheter after surgery is to prevent urinary retention after surgery, but it is known that the risk of urinary tract infection increases the longer it is maintained. Previously, it was removed 3 days after colorectal cancer surgery, but several studies reported that even if it was removed earlier, the incidence of urinary retention did not increase, and rather the incidence of urinary tract infection decreased. In particular, by applying the early recovery program after surgery, factors related to patient recovery before, during, and after surgery are applied to help rapid recovery, and it has been reported that early removal of the urinary catheter has a positive effect on postoperative recovery and complications. Therefore, it is necessary to prove that the timing of removal of the urinary catheter after surgery in colorectal cancer patients can help early recovery through clinical results such as patient recovery and occurrence of complications.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
316

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
8mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Dec 2024Dec 2026

Study Start

First participant enrolled

December 1, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

December 30, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

January 10, 2025

Status Verified

November 1, 2024

Enrollment Period

1.1 years

First QC Date

December 30, 2024

Last Update Submit

January 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of acute urinary retention due to failure to void spontaneously within 4 hours after removal of a urinary drain

    \- Definition of acute urinary retention: Failure to urinate spontaneously within 4 hours after removal of the urinary drainage tube or occurrence of residual volume greater than 400 ml as measured by ultrasound

    3 days after surgery

Secondary Outcomes (7)

  • Incidence of urinary drainage tube reinsertion rates

    7 days after surgery

  • Incidence of symptomatic urinary tract infections (UTIs)

    30 days postoperatively

  • postoperative pain scores

    3 days after surgery

  • Postoperative narcotic analgesic use rate

    3 days after surgery

  • early walking success rates

    3 days after surgery

  • +2 more secondary outcomes

Study Arms (2)

Immediate UC removal after surgery

EXPERIMENTAL

A urinary catheter is removed immediately after surgery and before general anesthesia wears off,

Device: Immediate urinary catheter removal

UC removal within 24hr after surgery

ACTIVE COMPARATOR

A urinary catheter is removed in the ward within postoperative 1 day (within 24 hours after surgery).

Device: urinary catheter removal within postoperative 1day

Interventions

A urinary catheter is removed immediately after surgery and before general anesthesia wears off in the operating room.

Immediate UC removal after surgery

The urethral catheter will be removed in the ward within 1 day after surgery (within 24 hours after surgery).

UC removal within 24hr after surgery

Eligibility Criteria

Age19 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old 80 years old
  • Patients diagnosed with colorectal cancer who are eligible for radical resection surgery
  • Patients who underwent open, laparoscopic, or robotic surgery
  • Written informed consent

You may not qualify if:

  • Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time
  • Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc.
  • Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection
  • Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent
  • Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past
  • Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure
  • Patients who cannot participate in a clinical trial at the discretion of a physician
  • Patients who do not wish to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul St.Mary's hospital, the Catholic university of Korea

Seoul, Seoul, 06591, South Korea

Location

MeSH Terms

Conditions

Colorectal NeoplasmsPostoperative Complications

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Patients, care provider and surgeons will be unaware of randomized assignment until the end of surgery.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: prospective, randomized controlled, non-inferior, multi-center trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 30, 2024

First Posted

January 10, 2025

Study Start

December 1, 2024

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

January 10, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations